Danaher Corporation Stock Price, News & Analysis

Danaher Corporation (NYSE: DHR) has declared a quarterly cash dividend of $0.25 per share for common stock, payable on April 29, 2022, to shareholders on record by March 25, 2022. Additionally, dividends for preferred stocks include $11.875 for its 4.75% Series A and $12.50 for its 5.00% Series B, both payable on April 15, 2022, to shareholders on record by March 31, 2022. This indicates continued shareholder returns and reflects the company’s confidence in its financial health.

Danaher Corporation (NYSE: DHR) announced strong financial results for Q4 and full year 2021. Q4 net earnings reached $1.8 billion, or $2.39 per share, a 44% increase year-over-year, with revenues of $8.1 billion, up 20.5%. Full year net earnings were $6.3 billion ($8.50 per share), a 74% rise, while revenues increased 32% to $29.5 billion. Operating cash flow rose 34.5% to $8.4 billion. CEO Rainer M. Blair highlighted a transformative year with strategic acquisitions totaling $11 billion and a strong foundation for future growth. The company projects high-single digit core revenue growth for 2022.

Pall Corporation, a subsidiary of Danaher, unveiled the Supralon hydraulic and lube oil filter element range on January 11, 2022. This product upgrade enhances existing filter lines, employing stress-resistant technology for better equipment protection. It promises reduced energy costs and lower maintenance expenses, thereby decreasing total filtration costs. Supralon filters match the form and function of previous models and can retrofit into existing systems to improve fluid cleanliness. The older filter models will be phased out in the coming months.

Danaher Corporation (DHR) announced its CEO, Rainer M. Blair, will discuss the company's strong fourth quarter 2021 results at the J.P. Morgan Healthcare Conference. Core revenue growth is expected to exceed prior guidance, with estimated revenues increasing by high-teens to low-twenties percent year-over-year. This growth is driven by exceptional performance in Life Sciences and Diagnostics, alongside a notable 10% rise in core business. The quarterly earnings call is set for January 27, 2022, to provide further insights.

Danaher Corporation (NYSE: DHR) announced that CEO Rainer M. Blair will present at the J.P. Morgan Healthcare Conference on January 11, 2022, at 11:15 a.m. ET. The presentation will be webcast live and archived on Danaher's website.

Danaher is a global science and technology innovator focused on solving complex challenges in the healthcare, environmental, and applied end-markets. With about 69,000 associates across more than 20 operating companies, Danaher aims to improve quality of life worldwide.

Danaher Corporation (NYSE: DHR) has announced its quarterly earnings conference call for Q4 2021, scheduled on January 27, 2022, at 8:00 a.m. ET. The call will last around 1 hour and will be accessible via a live webcast on Danaher’s website under the 'Investors' section. A replay will be available after the event. Interested parties can join the call by dialing 800-895-3361 (U.S.) or +1 785-424-1062 (internationally) before the start time. The earnings press release and related materials will be posted online at 6:00 a.m. ET on the same day.

Danaher Corporation (NYSE: DHR) has announced a regular quarterly cash dividend of $0.21 per share on common stock, payable on January 28, 2022, to shareholders of record on December 30, 2021. Additionally, the Board approved a quarterly cash dividend of $11.875 per share of its 4.75% Series A Preferred Stock and $12.50 per share of its 5.00% Series B Preferred Stock, both payable on January 15, 2022, to holders of record on December 31, 2021.

Danaher Corporation (NYSE: DHR) has priced an offering of $1 billion in 2.800% senior notes due 2051, with an offering price set at 99.396% of the principal amount. The expected net proceeds are approximately $984 million, intended for redeeming all outstanding 2.500% senior notes due 2025, refinancing debt, working capital, and other corporate purposes. The offering is anticipated to close on December 10, 2021, subject to customary conditions. This move is part of Danaher's strategy to manage its debt efficiently.

IDBS, a Danaher operating company, launched Polar Insight, enhancing its BioPharma Lifecycle Management (BPLM) platform with advanced data analytics and visualization tools. This innovation replaces outdated manual processes, allowing for integrated digital workflows that streamline data handling from development to manufacturing. The new capabilities aim to accelerate innovation and regulatory filings, enabling clients to deliver vaccines and therapies more efficiently. The first dashboards will be available in Q1 2022.